A low CD4/CD8 ratio has been associated to AIDS and non-AIDS associated events. Long-term side effects have led to non-conventional NRTIsparing regimens. Aim of the study was to evaluate if the switch to mono/dual therapy could determine a change in CD4/CD8 ratio.

CD4/CD8 ratio in patients who switch cART therapy: triple drug regimen could be better than mono/dual?

G. Nunnari;G. F. Pellicanò.
2017-01-01

Abstract

A low CD4/CD8 ratio has been associated to AIDS and non-AIDS associated events. Long-term side effects have led to non-conventional NRTIsparing regimens. Aim of the study was to evaluate if the switch to mono/dual therapy could determine a change in CD4/CD8 ratio.
2017
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3141780
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact